International Publisher of Science, Technology and Medicine

 
 
Track Your Manuscript
 
 
 
 
International Journal of Cardiovascular Research
Editor-in-chief: Jimmy T Efird, PhD       Interview
East Carolina Heart Institute,
Brody School of Medicine, USA
ISSN: 2324-8602
Frequency: Bimonthly
 
 
The International Journal of Cardiovascular Research (ICRJ) promotes rigorous research that makes a significant contribution in advancing knowledge in the fields of Cardiology & Medicine.
 
International Journal of Cardiovascular Research is a subscription based journal that provides a range of options to purchase our articles and also permits unlimited Internet Access to complete Journal content. It accepts research, review papers, online letters to the editors & brief comments on previously published articles or other relevant findings in SciTechnol. Articles submitted by authors are evaluated by a group of peer review experts in the field and ensures that the published articles are of high quality, reflect solid scholarship in their fields, and that the information they contain is accurate and reliable.
 
Upcoming Conference: 4th International Conference on Clinical & Experimental Cardiology
 
Current Issue
Editors & Editorial Board Members  
Int J Cardiovasc Res 2013, 3:1   
  PDF   
Specificity of the Cardiocerebral-Event Reductions in the Kyoto Heart and Jikei Heart Study   Commentary
Hisato Takagi and Takuya Umemoto
Int J Cardiovasc Res 2014, 3:1    doi: 10.4172/2324-8602.1000156
 Preview

Specificity of the Cardiocerebral-Event Reductions in the Kyoto Heart and Jikei Heart Study

The Kyoto Heart Study was a prospective randomized open blinded end-point (PROBE)-design trial, in which 3031 Japanese patients (mean, 66 years) with uncontrolled hypertension were randomized to either valsartan add-on or non-angiotensin receptor blocker (ARB) treatment.

|  Full Text |   PDF   
Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage   Research Article
Vladimir I Morozov, Michael I Kalinski, Jason Jaggers, Nikolay V Goncharov and Galina A Sakuta
Int J Cardiovasc Res 2014, 3:1    doi: 10.4172/2324-8602.1000157
 Preview

Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage

This is an overview of literature data on ischemia-modified albumin (IMA) and its potential as a marker of myocardium and skeletal muscle damage. Characteristics and properties of IMA are considered. IMA can be used as a nonspecific variable of ischemic conditions but IMA fails to differentiate between ischemic tissues. As a marker of ischemic conditions IMA may be used in combinations with other markers.

|  Full Text |   PDF   
Left Atrial Myxoma Associated with Advanced Atrioventricular Block in a Very Elderly Woman   Case Report
Elia De Maria, Lorenzo Bonetti, Alina Olaru and Stefano Cappelli
Int J Cardiovasc Res 2014, 3:1    doi: 10.4172/2324-8602.1000158
 Preview

Left Atrial Myxoma Associated with Advanced Atrioventricular Block in a Very Elderly Woman

Primary cardiac tumors are rare and only 10% of them are malignant. Nearly 80% of benign forms are myxomas that usually develop in the atria, 75% originating in the left atrium and 15-20% in the right atrium.

|  Full Text |   PDF   
Amiodarone-Induced Life- Threatening Ventricular Arrhythmias in a Patient with Cerebrogenic QT Interval Prolongation. Clinical Implications   Case Report
Vincenzo Marafioti, Vincenzo Carbone and Giuseppe Oreto
Int J Cardiovasc Res 2014, 3:1    doi: 10.4172/2324-8602.1000159
 Preview

Amiodarone-Induced Life- Threatening Ventricular Arrhythmias in a Patient with Cerebrogenic QT Interval Prolongation. Clinical Implications

Acquired causes of abnormal QT interval prolongation include drug effect, toxins, electrolyte imbalance, hypothermia, severe bradyarrhythmias, myocardial ischemia, heart failure, altered nutritional states, hypothyroidism, Coxsackie B3 myocarditis, immunodeficiency virus syndrome.

|  Full Text |   PDF